This session discusses the presentation, evaluation, and treatment of Crohn's disease and ulcerative colitis and the latest controversies and the direction of future therapies in inflammatory bowel disease.
Contact hours available until 9/27/2017.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure:
Planning Committee Member Tammy Mitchell discloses that she holds stock with Hill-Rom.
Speaker: Peter Buch discloses that he is a member of the speakers’ bureau for AbbVie.
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA)
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
Objectives: 1. Distinguish inflammatory bowel disease (IBD) from irritable bowel disease (IBS). 2. Review the workup of IBD. 3. Identify the various treatments of IBD. 4. Discuss the controversies surrounding IBD.